SEC Targets 2 Cos. Over Misleading COVID-19 Claims
The U.S. Securities and Exchange Commission took aim at two unrelated companies that purported to offer products to combat COVID-19, accusing them of defrauding the public and artificially inflating their share...To view the full article, register now.
Already a subscriber? Click here to view full article